We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high ...

Despite a tough start to 2025, the stock has gained about 9% in the past 12 months. U.S.-listed shares of BioNTech (BNTX) lost ground Monday, as the COVID-19 vaccine maker’s soft outlook for ...

The general mood among these heavyweight investors is divided, with 25% leaning bullish and 62% bearish. Among these notable ...

European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 ...

CureVac (CVAC) announced that the European Patent Office has confirmed the validity of the company’s European patent EP 3 708 668 B1 subject to ...

pushed its stock nearly 16% higher during the trading session. By contrast, the S&P 500 (SNPINDEX: ^GSPC) could only muster a 1.1% gain. Earlier that day, a court in Düsseldorf, Germany ruled ...

DUESSELDORF, Germany (Reuters) -A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In a statement, the court in the city of ...

The outcome of these discussions will be closely monitored by investors and could influence BioNTech’s stock performance in the near term. This article was generated with the support of AI and ...